These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 3337024)

  • 41. The electrophysiologic effects of procainamide in the immature heart.
    Shih JY; Gillette PC; Kugler JD; Garson A; Fukushige J; Zinner A; Driscoll DJ
    Pediatr Pharmacol (New York); 1982; 2(1):65-73. PubMed ID: 7110758
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Amiodarone or procainamide for the termination of sustained stable ventricular tachycardia: an historical multicenter comparison.
    Marill KA; deSouza IS; Nishijima DK; Senecal EL; Setnik GS; Stair TO; Ruskin JN; Ellinor PT
    Acad Emerg Med; 2010 Mar; 17(3):297-306. PubMed ID: 20370763
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Influence of glucagon on the cardiovascular effects of procainamide.
    Prasad K; Weckworth P
    Angiology; 1977 Aug; 28(8):515-27. PubMed ID: 883680
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Simultaneous anterograde fast-slow atrioventricular nodal pathway conduction after procainamide.
    Gomes JA; Kang PS; Kelen G; Khan R; El-Sherif N
    Am J Cardiol; 1980 Oct; 46(4):677-84. PubMed ID: 7416027
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of quinidine versus procainamide on the QT interval.
    Reiter MJ; Higgins SL; Payne AG; Mann DE
    Am J Cardiol; 1986 Sep; 58(6):512-6. PubMed ID: 3751914
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of intravenous amiodarone on ventricular refractoriness, intraventricular conduction, and ventricular tachycardia induction.
    Kułakowski P; Karczmarewicz S; Karpiński G; Soszyńska M; Ceremuzyński L
    Europace; 2000 Jul; 2(3):207-15. PubMed ID: 11227590
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects on ventricular function of disopyramide, procainamide and quinidine as determined by radionuclide angiography.
    Wisenberg G; Zawadowski AG; Gebhardt VA; Prato FS; Goddard MD; Nichol PM; Rechnitzer PA; Gryfe-Becker B
    Am J Cardiol; 1984 May; 53(9):1292-7. PubMed ID: 6711431
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Procainamide infusion and acute atrial fibrillation.
    Fulham MJ; Cookson WO; Sher M
    Anaesth Intensive Care; 1984 May; 12(2):121-4. PubMed ID: 6476345
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Electropharmacologic effects and pharmacokinetics of almokalant, a new class III antiarrhythmic, in patients with healed or healing myocardial infarcts and complex ventricular arrhythmias.
    Wiesfeld AC; Crijns HJ; Tobé TJ; Almgren O; Bergstrand RH; Aberg J; Haaksma J; Lie KI
    Am J Cardiol; 1992 Oct; 70(11):990-6. PubMed ID: 1384304
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effects of programmed ventricular stimulation on plasma procainamide levels: an experimental model.
    Brautigam RT; Porter S; Kutalek SP
    J Clin Pharmacol; 1994 Feb; 34(2):184-91. PubMed ID: 8163719
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Procainamide pharmacokinetics in patients with acute myocardial infarction or congestive heart failure.
    Kessler KM; Kayden DS; Estes DM; Koslovskis PL; Sequeira R; Trohman RG; Palomo AR; Myerburg RJ
    J Am Coll Cardiol; 1986 May; 7(5):1131-9. PubMed ID: 3958372
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Maintenance therapy with a new retard tablet preparation of procainamide.
    Hansteen V; Landmark KH; Fremstad D; Dahl SG; Jacobsen S; Marthinsen AA; Waaler T; Frislid K; Lunde PK
    Am Heart J; 1976 Jul; 92(1):47-56. PubMed ID: 785987
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Strength-interval relation in the human ventricle: effect of procainamide.
    Camardo JS; Greenspan AM; Horowitz LN; Spielman SR; Josephson ME
    Am J Cardiol; 1980 Apr; 45(4):856-60. PubMed ID: 7361675
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Survival after massive procainamide ingestion.
    Villalba-Pimentel L; Epstein LM; Sellers EM; Foster JR; Bennion LJ; Nadler LM; Bough EW; Koch-Weser J
    Am J Cardiol; 1973 Oct; 32(5):727-30. PubMed ID: 4744699
    [No Abstract]   [Full Text] [Related]  

  • 55. Hypersensitivity reaction associated with acute hepatic dysfunction following a single intravenous dose of procainamide.
    Worman HJ; Ip JH; Winters SL; Tepper DC; Gomes AJ
    J Intern Med; 1992 Oct; 232(4):361-3. PubMed ID: 1402640
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Factors influencing procainamide total body clearance in the immediate postmyocardial infarction period.
    Wyman MG; Goldreyer BN; Cannon DS; Ludden TM; Lalka D
    J Clin Pharmacol; 1981 Jan; 21(1):20-5. PubMed ID: 7217340
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The effect of procainamide on plasma cholinesterase activity.
    Kambam JR; Naukam RJ; Sastry BV
    Can J Anaesth; 1987 Nov; 34(6):579-81. PubMed ID: 3677282
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Bolus Intravenous Procainamide in Patients with Frequent Ventricular Ectopics during Cardiac Magnetic Resonance Scanning: A Way to Ensure High Quality Imaging.
    Nikolaidou C; Kouskouras K; Fragakis N; Vassilikos VP; Karvounis H; Karamitsos TD
    Diagnostics (Basel); 2021 Jan; 11(2):. PubMed ID: 33513676
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Procainamide accumulation kinetics in the immediate postmyocardial infarction period.
    Lalka D; Wyman MG; Goldreyer BN; Ludden TM; Cannom DS
    J Clin Pharmacol; 1978; 18(8-9):397-401. PubMed ID: 690250
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Drug-induced narrowing of the width of the zone of entrainment as a predictor of the subsequent non-inducibility of reentrant ventricular tachycardia after an additional dose of an antiarrhythmic drug.
    Aizawa Y; Chinushi M; Naitoh N; Shibata A
    Heart; 1996 Feb; 75(2):165-70. PubMed ID: 8673755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.